Dan O'Day, Gilead CEO (Jim Watson/AFP via Getty Images)
Gilead finds 'critical holes' in the government's HIV patent case against it
Gilead’s hoping for a swift end to its HIV patent battle with HHS, filing for a summary judgment on Thursday. If the motion is granted …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
